Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Federman Holdings is a prominent Israeli private investment company led by the Federman family, primarily known for its controlling interest in Elbit Systems and Dan Hotels. Within the life sciences and healthcare sectors, the company operates through its significant holdings in Elbit Systems, which in turn controls Elbit Medical Technologies. Through these vehicles, Federman Holdings has been a key investor and stakeholder in major medical technology and biotechnology firms, including Insightec, which specializes in MR-guided focused ultrasound, and Gamida Cell, a leader in cell therapy. The group's involvement in healthcare spans medical imaging, therapeutic devices, and advanced cell-based medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Federman Holdings.